{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:17:05Z","timestamp":1790752625951,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006678","name":"Association Fran\u00e7aise pour l'Etude du Foie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006678","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016147","name":"Korean Association for the Study of the Liver","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.clinre.2014.03.001","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T09:38:55Z","timestamp":1403170735000},"page":"557-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["ABCB4: Insights from pathobiology into therapy"],"prefix":"10.1016","volume":"38","author":[{"given":"Thomas","family":"Falgui\u00e8res","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tounsia","family":"A\u00eft-Slimane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Housset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Maurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2014.03.001_bib0005","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/j.2040-4603.2013.tb00519.x","article-title":"Bile formation and secretion","volume":"3","author":"Boyer","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1016\/j.clinre.2014.03.001_bib0010","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1172\/JCI105794","article-title":"The physicochemical basis of cholesterol gallstone formation in man","volume":"47","author":"Admirand","year":"1968","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2014.03.001_bib0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.me.18.020167.002001","article-title":"Detergent properties of bile salts: correlation with physiological function","volume":"18","author":"Hofmann","year":"1967","journal-title":"Annu Rev Med"},{"issue":"Suppl.","key":"10.1016\/j.clinre.2014.03.001_bib0020","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1194\/jlr.R800075-JLR200","article-title":"Biliary lipids and cholesterol gallstone disease","volume":"50","author":"Wang","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinre.2014.03.001_bib0025","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jhep.2009.11.012","article-title":"Liver disease associated with canalicular transport defects: current and future therapies","volume":"52","author":"Stapelbroek","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2014.03.001_bib0030","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","article-title":"The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood","volume":"120","author":"Jacquemin","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0035","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1053\/gast.2001.23947","article-title":"MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis","volume":"120","author":"Rosmorduc","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0040","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0016-5085(03)00898-9","article-title":"ABCB4 gene mutation-associated cholelithiasis in adults","volume":"125","author":"Rosmorduc","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.gastro.2008.03.044","article-title":"ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults","volume":"135","author":"Ziol","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0050","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0030-1253223","article-title":"The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects","volume":"30","author":"Davit-Spraul","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2014.03.001_bib0055","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3748\/wjg.15.2049","article-title":"Intrahepatic cholestasis of pregnancy","volume":"15","author":"Geenes","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"Suppl. 1","key":"10.1016\/j.clinre.2014.03.001_bib0060","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S2210-7401(12)70019-0","article-title":"Low phospholipid-associated cholestasis and cholelithiasis","volume":"36","author":"Erlinger","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2014.03.001_bib0065","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/hep.510250303","article-title":"Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis","volume":"25","author":"Jacquemin","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0070","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1002\/j.1460-2075.1987.tb02653.x","article-title":"The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver","volume":"6","author":"Van der Bliek","year":"1987","journal-title":"EMBO J"},{"key":"10.1016\/j.clinre.2014.03.001_bib0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0378-1119(88)90057-1","article-title":"Sequence of mdr3 cDNA encoding a human P-glycoprotein","volume":"71","author":"van der Bliek","year":"1988","journal-title":"Gene"},{"key":"10.1016\/j.clinre.2014.03.001_bib0080","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1016\/S0021-9258(19)67788-4","article-title":"Structure of the human MDR3 gene and physical mapping of the human MDR locus","volume":"266","author":"Lincke","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2014.03.001_bib0085","doi-asserted-by":"crossref","first-page":"23530","DOI":"10.1074\/jbc.M909002199","article-title":"MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping","volume":"275","author":"Smith","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2014.03.001_bib0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.clinre.2014.03.001_bib0095","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0092-8674(94)90446-4","article-title":"Phosphatidylcholine translocase: a physiological role for the mdr2 gene","volume":"77","author":"Ruetz","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.clinre.2014.03.001_bib0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-5793(94)01135-4","article-title":"The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice","volume":"354","author":"Smith","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clinre.2014.03.001_bib0105","first-page":"638","article-title":"Tissue distribution of the human MDR3 P-glycoprotein","volume":"71","author":"Smit","year":"1994","journal-title":"Lab Invest"},{"key":"10.1016\/j.clinre.2014.03.001_bib0110","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gr.184901","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"11","author":"Dean","year":"2001","journal-title":"Genome Res"},{"key":"10.1016\/j.clinre.2014.03.001_bib0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/bse0500043","article-title":"Structure of ABC transporters","volume":"50","author":"Zolnerciks","year":"2011","journal-title":"Essays Biochem"},{"key":"10.1016\/j.clinre.2014.03.001_bib0120","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.clinre.2014.03.001_bib0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1096\/fasebj.11.1.9034162","article-title":"Hepatic canalicular membrane 1: the role of mdr2 P-glycoprotein in hepatobiliary lipid transport","volume":"11","author":"Oude Elferink","year":"1997","journal-title":"FASEB J"},{"key":"10.1016\/j.clinre.2014.03.001_bib0130","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/S0022-2275(20)39199-9","article-title":"Imaging biliary lipid secretion in the rat: ultrastructural evidence for vesiculation of the hepatocyte canalicular membrane","volume":"36","author":"Crawford","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinre.2014.03.001_bib0135","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.21591","article-title":"Bile salt-dependent efflux of cellular phospholipids mediated by ATP binding cassette protein B4","volume":"46","author":"Morita","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0140","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0168-8278(02)00129-0","article-title":"Nuclear receptor regulation of hepatic function","volume":"36","author":"Karpen","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2014.03.001_bib0145","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1042\/bj3140781","article-title":"Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse","volume":"314","author":"Chianale","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.clinre.2014.03.001_bib0150","doi-asserted-by":"crossref","first-page":"51085","DOI":"10.1074\/jbc.M308321200","article-title":"Farnesoid X receptor activates transcription of the phospholipid pump MDR3","volume":"278","author":"Huang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2014.03.001_bib0155","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1872-034X.2007.00069.x","article-title":"Bezafibrate induces multidrug-resistance P-glycoprotein 3 expression in cultured human hepatocytes and humanized livers of chimeric mice","volume":"37","author":"Shoda","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinre.2014.03.001_bib0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.physiol.65.092101.142528","article-title":"Nuclear receptors and the control of metabolism","volume":"65","author":"Francis","year":"2003","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.clinre.2014.03.001_bib0165","doi-asserted-by":"crossref","first-page":"28857","DOI":"10.1074\/jbc.M011610200","article-title":"Human bile salt export pump promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"276","author":"Ananthanarayanan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2014.03.001_bib0170","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1194\/jlr.M027433","article-title":"Metabolomics reveals an essential role for peroxisome proliferator-activated receptor alpha in bile acid homeostasis","volume":"53","author":"Li","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinre.2014.03.001_bib0175","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0016-5085(99)70462-2","article-title":"3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats","volume":"117","author":"Hooiveld","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0180","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0168-8278(03)00049-7","article-title":"Progressive familial intrahepatic cholestasis type 3 revealed by oral contraceptive pills","volume":"38","author":"Ganne-Carrie","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2014.03.001_bib0185","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.26424","article-title":"Genotype-phenotype relationships in the low-phospholipid associated cholelithiasis syndrome. A study of 156 consecutive patients","volume":"58","author":"Poupon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0190","doi-asserted-by":"crossref","first-page":"15917","DOI":"10.1074\/jbc.M909875199","article-title":"Newly synthesized canalicular ABC transporters are directly targeted from the Golgi to the hepatocyte apical domain in rat liver","volume":"275","author":"Kipp","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2014.03.001_bib0195","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1146\/annurev.physiol.64.081501.155793","article-title":"Trafficking of canalicular ABC transporters in hepatocytes","volume":"64","author":"Kipp","year":"2002","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.clinre.2014.03.001_bib0200","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1091\/mbc.e02-08-0528","article-title":"Raft-mediated trafficking of apical resident proteins occurs in both direct and transcytotic pathways in polarized hepatic cells: role of distinct lipid microdomains","volume":"14","author":"A\u00eft-Slimane","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.clinre.2014.03.001_bib0205","doi-asserted-by":"crossref","first-page":"32761","DOI":"10.1074\/jbc.M404337200","article-title":"Identification of HAX-1 as a protein that binds bile salt export protein and regulates its abundance in the apical membrane of Madin-Darby canine kidney cells","volume":"279","author":"Ortiz","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2014.03.001_bib0210","doi-asserted-by":"crossref","first-page":"23741","DOI":"10.1074\/jbc.M502767200","article-title":"Myosin II regulatory light chain is required for trafficking of bile salt export protein to the apical membrane in Madin-Darby canine kidney cells","volume":"280","author":"Chan","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2014.03.001_bib0215","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1872-034X.2009.00544.x","article-title":"Receptor for activated C-kinase 1 regulates the cellular localization and function of ABCB4","volume":"39","author":"Ikebuchi","year":"2009","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinre.2014.03.001_bib0220","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/hep.25523","article-title":"A C-terminal tyrosine-based motif in the bile salt export pump directs clathrin-dependent endocytosis","volume":"55","author":"Lam","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0225","doi-asserted-by":"crossref","first-page":"40099","DOI":"10.1074\/jbc.M206964200","article-title":"PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator","volume":"277","author":"Swiatecka-Urban","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2014.03.001_bib0230","doi-asserted-by":"crossref","first-page":"19299","DOI":"10.1074\/jbc.M109.096081","article-title":"NHERF-1 binds to Mrp2 and regulates hepatic Mrp2 expression and function","volume":"285","author":"Li","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2014.03.001_bib0235","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hep.510230435","article-title":"Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis","volume":"23","author":"Deleuze","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0240","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1172\/JCI109025","article-title":"The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man","volume":"61","author":"Carey","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2014.03.001_bib0245","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/sj.ejhg.5201908","article-title":"Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3)","volume":"15","author":"Degiorgio","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clinre.2014.03.001_bib0250","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1478-3231.2009.02148.x","article-title":"Combined features of low phospholipid-associated cholelithiasis and progressive familial intrahepatic cholestasis 3","volume":"30","author":"Poupon","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2014.03.001_bib0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MPG.0b013e3181f50363","article-title":"Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations","volume":"52","author":"Colombo","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2014.03.001_bib0260","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.dld.2011.03.004","article-title":"Two novel mutations in African and Asian children with progressive familial intrahepatic cholestasis type 3","volume":"43","author":"Giovannoni","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2014.03.001_bib0265","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MPG.0b013e31824ef36f","article-title":"Chinese children with chronic intrahepatic cholestasis and high gamma-glutamyl transpeptidase: clinical features and association with ABCB4 mutations","volume":"55","author":"Fang","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2014.03.001_bib0270","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.20682","article-title":"Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis","volume":"41","author":"Keitel","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0275","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1053\/j.gastro.2006.05.003","article-title":"Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy","volume":"131","author":"Keitel","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0280","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.gene.2012.06.029","article-title":"The histidine-loop is essential for transport activity of human MDR3. A novel mutation of MDR3 in a patient with progressive familial intrahepatic cholestasis type 3","volume":"506","author":"Dzagania","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.clinre.2014.03.001_bib0285","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00428-012-1202-6","article-title":"Aspects of liver pathology in adult patients with MDR3\/ABCB4 gene mutations","volume":"460","author":"Wendum","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1016\/j.clinre.2014.03.001_bib0290","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/hmg\/9.8.1209","article-title":"Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking","volume":"9","author":"Dixon","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clinre.2014.03.001_bib0295","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/hep.22775","article-title":"A missense mutation in ABCB4 gene involved in progressive familial intrahepatic cholestasis type 3 leads to a folding defect that can be rescued by low temperature","volume":"49","author":"Delaunay","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0300","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1074\/jbc.M111.275438","article-title":"Effects of cellular, chemical and pharmacological chaperones on the rescue of a trafficking-defective mutant of the ATP-binding cassette transporters ABCB1\/ABCB4","volume":"287","author":"Gautherot","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2014.03.001_bib0305","article-title":"Two ABCB4 point mutations of strategic NBD-motifs do not prevent protein targeting to the plasma membrane but promote MDR3 dysfunction","author":"Degiorgio","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clinre.2014.03.001_bib0310","article-title":"A molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4","author":"Andress","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0315","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"EASL","year":"2009","journal-title":"J Hepatol"},{"issue":"Suppl. 1","key":"10.1016\/j.clinre.2014.03.001_bib0320","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S2210-7401(12)70015-3","article-title":"Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action","volume":"36","author":"Poupon","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2014.03.001_bib0325","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.gastro.2005.10.018","article-title":"24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"130","author":"Fickert","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0330","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.22891","article-title":"Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2\u2212\/\u2212 mice","volume":"49","author":"Halilbasic","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0335","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jhep.2013.01.026","article-title":"Differential effects of norUDCA and UDCA in obstructive cholestasis in mice","volume":"58","author":"Fickert","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2014.03.001_bib0340","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/bj20020981","article-title":"Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice","volume":"369","author":"Kok","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.clinre.2014.03.001_bib0345","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5414\/CPP48022","article-title":"Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway","volume":"48","author":"Nakamuta","year":"2010","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clinre.2014.03.001_bib0350","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/hep.26894","article-title":"PPARalpha activates human multidrug resistance transporter 3\/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion","volume":"59","author":"Ghonem","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0355","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1023\/A:1005643014395","article-title":"Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population","volume":"46","author":"Caroli-Bosc","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2014.03.001_bib0360","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/jm025529g","article-title":"6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity","volume":"45","author":"Pellicciari","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.clinre.2014.03.001_bib0365","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jhep.2012.04.017","article-title":"Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2","volume":"57","author":"Gonzales","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2014.03.001_bib0370","doi-asserted-by":"crossref","first-page":"a009761","DOI":"10.1101\/cshperspect.a009761","article-title":"Cystic fibrosis transmembrane regulator correctors and potentiators","volume":"3","author":"Rowe","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.clinre.2014.03.001_bib0375","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1172\/JCI24898","article-title":"Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening","volume":"115","author":"Pedemonte","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2014.03.001_bib0380","doi-asserted-by":"crossref","first-page":"L1117","DOI":"10.1152\/ajplung.00169.2005","article-title":"Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules","volume":"290","author":"Van Goor","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.clinre.2014.03.001_bib0385","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/emmm.201302699","article-title":"Discovery of novel potent DeltaF508-CFTR correctors that target the nucleotide binding domain","volume":"5","author":"Odolczyk","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.clinre.2014.03.001_bib0390","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tips.2007.05.004","article-title":"Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis","volume":"28","author":"Amaral","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.clinre.2014.03.001_bib0395","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1053\/gast.2000.20222","article-title":"Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis","volume":"119","author":"De Vree","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2014.03.001_bib0400","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.trsl.2012.12.001","article-title":"Gene therapy in cystic fibrosis","volume":"161","author":"Prickett","year":"2013","journal-title":"Transl Res"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740114000564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740114000564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:20:41Z","timestamp":1761895241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740114000564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S2210740114000564"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2014.03.001","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ABCB4: Insights from pathobiology into therapy","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2014.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}